• Return to Headlines

Highest Debt to Asset Ratio in the Biotechnology Industry Detected in Shares of Agenus Inc (AGEN, NVAX, KERX, TTOO, ICPT)

By Nick Russo

Below are the three companies in the Biotechnology industry with the highest debt to asset ratios. The Debt/Asset ratio shows the proportion of a company's assets that are financed through debt. If the ratio is greater than one, most of the company's assets are financed through debt.

Agenus Inc ranks highest with a a debt to asset ratio of 117.79. Novavax Inc is next with a a debt to asset ratio of 105.05. Keryx Biopharm ranks third highest with a a debt to asset ratio of 78.68.

T2 Biosystems follows with a a debt to asset ratio of 76.02, and Intercept Pharma rounds out the top five with a a debt to asset ratio of 73.43.

SmarTrend recommended that its subscribers protect gains by selling shares of Intercept Pharma on April 12th, 2019 by issuing a Downtrend alert when the shares were trading at $98.45. Since that call, shares of Intercept Pharma have fallen 17.7%. We are now looking for when a new Uptrend will commence and will alert SmarTrend subscribers in real time.

Keywords: highest debt to asset ratio agenus inc novavax inc keryx biopharm t2 biosystems intercept pharma

Ticker(s): AGEN NVAX KERX TTOO ICPT